首页 > 最新文献

Efort Open Reviews最新文献

英文 中文
Calcitonin treatment for osteoarthritis and rheumatoid arthritis - a systematic review and meta-analysis of preclinical data. 骨关节炎和类风湿性关节炎的降钙素治疗--临床前数据的系统回顾和荟萃分析。
IF 4.3 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-07-01 DOI: 10.1530/EOR-23-0133
Mara Meyer Günderoth, Alexandra Bannach-Brown, Tobias Winkler, Johannes Keller, Robert Karl Zahn, Tazio Maleitzke

Purpose: The aim of this study was to investigate the efficacy of calcitonin (CT) in animal models of experimental osteoarthritis (OA) and rheumatoid arthritis (RA), as new stabilized CT formulations are currently being introduced.

Methods: A comprehensive and systemic literature search was conducted in PubMed/MEDLINE and Embase databases to identify articles with original data on CT treatment of preclinical OA and RA. Methodological quality was assessed using the Systematic Review Centre for Laboratory Animal Experimentation's risk of bias tool for animal intervention studies. To provide summary estimates of efficacy, a meta-analysis was conducted for outcomes reported in four or more studies, using a random-effects model. Subgroup analyses were employed to correct for study specifics.

Results: Twenty-six studies were ultimately evaluated and data from 16 studies could be analyzed in the meta-analysis, which included the following outcomes: bone mineral density, bone volume, levels of cross-linked C-telopeptide of type I collagen, histopathological arthritis score, and mechanical allodynia. For all considered outcome parameters, CT-treated groups were significantly superior to control groups (P = 0.002; P = 0.01; P < 0.00001; P < 0.00001; P = 0.04). For most outcomes, effect sizes were significantly greater in OA than in RA (P ≤ 0.025). High in-between study heterogeneity was detected.

Conclusion: There is preclinical evidence for an antioxidant, anti-inflammatory, antinociceptive, cartilage- and bone-protective effect of CT in RA and OA. Given these effects, CT presents a promising agent for the treatment of both diseases, although the potential seems to be greater in OA.

目的:本研究旨在调查降钙素(CT)在实验性骨关节炎(OA)和类风湿性关节炎(RA)动物模型中的疗效,因为目前正在引入新的稳定CT制剂:方法:在PubMed/MEDLINE和Embase数据库中进行了全面系统的文献检索,以确定具有CT治疗临床前OA和RA原始数据的文章。方法学质量采用实验室动物实验系统性审查中心的动物干预研究偏倚风险工具进行评估。为了提供疗效的简要估计值,采用随机效应模型对四项或更多研究中报告的结果进行了荟萃分析。采用分组分析来纠正研究的特殊性:最终评估了 26 项研究,在荟萃分析中分析了 16 项研究的数据,其中包括以下结果:骨矿物质密度、骨量、I 型胶原交联 C-肽水平、组织病理学关节炎评分和机械异感。在所有考虑的结果参数中,CT 治疗组明显优于对照组(P = 0.002;P = 0.01;P < 0.00001;P < 0.00001;P = 0.04)。在大多数结果中,OA的效应大小明显大于RA(P ≤ 0.025)。研究之间存在高度异质性:有临床前证据表明,CT对RA和OA具有抗氧化、抗炎、抗痛、软骨和骨保护作用。鉴于这些作用,CT 是治疗这两种疾病的一种很有前景的药物,但其在 OA 中的潜力似乎更大。
{"title":"Calcitonin treatment for osteoarthritis and rheumatoid arthritis - a systematic review and meta-analysis of preclinical data.","authors":"Mara Meyer Günderoth, Alexandra Bannach-Brown, Tobias Winkler, Johannes Keller, Robert Karl Zahn, Tazio Maleitzke","doi":"10.1530/EOR-23-0133","DOIUrl":"10.1530/EOR-23-0133","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to investigate the efficacy of calcitonin (CT) in animal models of experimental osteoarthritis (OA) and rheumatoid arthritis (RA), as new stabilized CT formulations are currently being introduced.</p><p><strong>Methods: </strong>A comprehensive and systemic literature search was conducted in PubMed/MEDLINE and Embase databases to identify articles with original data on CT treatment of preclinical OA and RA. Methodological quality was assessed using the Systematic Review Centre for Laboratory Animal Experimentation's risk of bias tool for animal intervention studies. To provide summary estimates of efficacy, a meta-analysis was conducted for outcomes reported in four or more studies, using a random-effects model. Subgroup analyses were employed to correct for study specifics.</p><p><strong>Results: </strong>Twenty-six studies were ultimately evaluated and data from 16 studies could be analyzed in the meta-analysis, which included the following outcomes: bone mineral density, bone volume, levels of cross-linked C-telopeptide of type I collagen, histopathological arthritis score, and mechanical allodynia. For all considered outcome parameters, CT-treated groups were significantly superior to control groups (P = 0.002; P = 0.01; P < 0.00001; P < 0.00001; P = 0.04). For most outcomes, effect sizes were significantly greater in OA than in RA (P ≤ 0.025). High in-between study heterogeneity was detected.</p><p><strong>Conclusion: </strong>There is preclinical evidence for an antioxidant, anti-inflammatory, antinociceptive, cartilage- and bone-protective effect of CT in RA and OA. Given these effects, CT presents a promising agent for the treatment of both diseases, although the potential seems to be greater in OA.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bias in published randomized trials that compare collagenase injection with percutaneous needle fasciotomy in the treatment of Dupuytren disease: a systematic review. 比较胶原酶注射与经皮穿刺筋膜切开术治疗杜普伊特伦病的已发表随机试验的偏差:系统性综述。
IF 4.3 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-07-01 DOI: 10.1530/EOR-23-0211
David Eckerdal, Hendrik Pakosta, Muhanned Ali, Isam Atroshi

Purpose: Controversy exists regarding the comparative efficacy of collagenase injection and percutaneous needle fasciotomy in the treatment of Dupuytren contracture. The randomized controlled trials (RCTs) that have compared the two treatment methods have reported results mostly implying similar treatment efficacy, durability, and complications. We aimed to review these RCTs regarding methodical quality and risk of bias.

Methods: We searched PubMed and Cochrane Library databases up to May 2023. All RCTs comparing collagenase injection with needle fasciotomy were included. Eligible articles were reviewed by two researchers, of whom one was blinded to each article's title, authors, year of publication, journal, and source of the studies. To assess methodical quality, we used the modified Jadad scale yielding a score of 0 (lowest quality) to 5 (highest quality). We assessed risk of bias with the Cochrane risk-of-bias tool (RoB 2).

Results: Five studies were eligible, comprising 204 patients treated with collagenase injection and 209 patients treated with needle fasciotomy. The modified Jadad score ranged from 1 to 2 points in the five studies, and the overall risk of bias was high in all studies. Pretrial protocols could be retrieved for only two studies, revealing important discrepancies with the published articles.

Conclusion: The published RCTs that have compared collagenase injection with needle fasciotomy in the treatment of Dupuytren contracture demonstrate a high risk of bias.

目的:在治疗杜普伊特伦挛缩症方面,胶原酶注射和经皮针式筋膜切开术的疗效比较存在争议。对这两种治疗方法进行比较的随机对照试验(RCT)报告的结果大多暗示治疗效果、持久性和并发症相似。我们旨在就方法质量和偏倚风险对这些 RCT 进行审查:我们检索了截至 2023 年 5 月的 PubMed 和 Cochrane Library 数据库。纳入了所有比较胶原酶注射与针式筋膜切开术的 RCT。符合条件的文章由两名研究人员进行审阅,其中一名研究人员对每篇文章的标题、作者、发表年份、期刊和研究来源进行盲审。为了评估研究方法的质量,我们采用了改良的贾达德评分法,从 0 分(质量最低)到 5 分(质量最高)不等。我们使用科克伦偏倚风险工具(RoB 2)评估偏倚风险:有五项研究符合条件,其中204名患者接受了胶原酶注射治疗,209名患者接受了针刺法筋膜切开术治疗。五项研究的改良 Jadad 评分从 1 分到 2 分不等,所有研究的总体偏倚风险都很高。只有两项研究的预试验方案可以检索到,这与已发表的文章存在重大差异:结论:已发表的研究性临床试验比较了胶原酶注射与针式筋膜切开术在治疗杜普伊特伦挛缩症中的应用,结果显示偏倚风险很高。
{"title":"Bias in published randomized trials that compare collagenase injection with percutaneous needle fasciotomy in the treatment of Dupuytren disease: a systematic review.","authors":"David Eckerdal, Hendrik Pakosta, Muhanned Ali, Isam Atroshi","doi":"10.1530/EOR-23-0211","DOIUrl":"10.1530/EOR-23-0211","url":null,"abstract":"<p><strong>Purpose: </strong>Controversy exists regarding the comparative efficacy of collagenase injection and percutaneous needle fasciotomy in the treatment of Dupuytren contracture. The randomized controlled trials (RCTs) that have compared the two treatment methods have reported results mostly implying similar treatment efficacy, durability, and complications. We aimed to review these RCTs regarding methodical quality and risk of bias.</p><p><strong>Methods: </strong>We searched PubMed and Cochrane Library databases up to May 2023. All RCTs comparing collagenase injection with needle fasciotomy were included. Eligible articles were reviewed by two researchers, of whom one was blinded to each article's title, authors, year of publication, journal, and source of the studies. To assess methodical quality, we used the modified Jadad scale yielding a score of 0 (lowest quality) to 5 (highest quality). We assessed risk of bias with the Cochrane risk-of-bias tool (RoB 2).</p><p><strong>Results: </strong>Five studies were eligible, comprising 204 patients treated with collagenase injection and 209 patients treated with needle fasciotomy. The modified Jadad score ranged from 1 to 2 points in the five studies, and the overall risk of bias was high in all studies. Pretrial protocols could be retrieved for only two studies, revealing important discrepancies with the published articles.</p><p><strong>Conclusion: </strong>The published RCTs that have compared collagenase injection with needle fasciotomy in the treatment of Dupuytren contracture demonstrate a high risk of bias.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Personalized total knee arthroplasty in patients with extra-articular deformities. 针对关节外畸形患者的个性化全膝关节置换术。
IF 4.3 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-07-01 DOI: 10.1530/EOR-23-0215
Gautier Beckers, Marc-Olivier Kiss, Vincent Massé, Michele Malavolta, Pascal-André Vendittoli

Over the years, with a better understanding of knee anatomy and biomechanics, superior implant designs, advanced surgical techniques, and the availability of precision tools such as robotics and navigation, a more personalized approach to total knee arthroplasty (TKA) has emerged. In the presence of extra-articular deformities, performing personalized TKA can be more challenging and specific considerations are required, since one has to deal with an acquired pathological anatomy. Performing personalized TKA surgery in patients with extra-articular deformities, the surgeon can: (1) resurface the joint, omitting the extra-articular deformity; (2) partially compensate the extra-articular deformity with intra-articular correction (hybrid technique), or (3) correct the extra-articular deformity combined with a joint resurfacing TKA (single stage or two-stage procedure). Omitting the acquired lower limb malalignment by resurfacing the knee has the advantages of respecting the joint surface anatomy and preserving soft tissue laxities. On the other hand, it maintains pathological joint load and lower limb kinematics with potentially detrimental outcomes. The hybrid technique can be performed in most cases. It circumvents complications associated with osteotomies and brings lower limb axes closer to native alignment. On the other hand, it creates some intra-articular imbalances, which may require soft tissue releases and/or constrained implants. Correcting the extra-articular deformity (through an osteotomy) in conjunction with joint resurfacing TKA represents the only true kinematic alignment technique, as it aims to reproduce native knee laxity and overall lower limb axis.

多年来,随着对膝关节解剖和生物力学的深入了解、卓越的植入物设计、先进的手术技术以及机器人和导航等精密工具的应用,一种更加个性化的全膝关节置换术(TKA)方法应运而生。在存在关节外畸形的情况下,进行个性化的 TKA 手术可能更具挑战性,而且由于需要处理后天的病理解剖,因此需要特别的考虑。在对存在关节外畸形的患者进行个性化 TKA 手术时,外科医生可以(1) 重铺关节面,忽略关节外畸形;(2) 通过关节内矫正(混合技术)部分补偿关节外畸形;或 (3) 结合关节重铺 TKA(单阶段或两阶段手术)矫正关节外畸形。通过膝关节置换术避免后天性下肢畸形具有尊重关节表面解剖结构和保留软组织松弛的优点。但另一方面,它保留了病理关节负荷和下肢运动学,可能会造成不良后果。混合技术适用于大多数病例。它避免了截骨带来的并发症,使下肢轴线更接近原生对齐。另一方面,它也会造成一些关节内的不平衡,可能需要进行软组织松解和/或限制性植入。矫正关节外畸形(通过截骨术)与关节置换 TKA 结合使用是唯一真正的运动学对位技术,因为其目的是再现原生膝关节松弛和整体下肢轴线。
{"title":"Personalized total knee arthroplasty in patients with extra-articular deformities.","authors":"Gautier Beckers, Marc-Olivier Kiss, Vincent Massé, Michele Malavolta, Pascal-André Vendittoli","doi":"10.1530/EOR-23-0215","DOIUrl":"10.1530/EOR-23-0215","url":null,"abstract":"<p><p>Over the years, with a better understanding of knee anatomy and biomechanics, superior implant designs, advanced surgical techniques, and the availability of precision tools such as robotics and navigation, a more personalized approach to total knee arthroplasty (TKA) has emerged. In the presence of extra-articular deformities, performing personalized TKA can be more challenging and specific considerations are required, since one has to deal with an acquired pathological anatomy. Performing personalized TKA surgery in patients with extra-articular deformities, the surgeon can: (1) resurface the joint, omitting the extra-articular deformity; (2) partially compensate the extra-articular deformity with intra-articular correction (hybrid technique), or (3) correct the extra-articular deformity combined with a joint resurfacing TKA (single stage or two-stage procedure). Omitting the acquired lower limb malalignment by resurfacing the knee has the advantages of respecting the joint surface anatomy and preserving soft tissue laxities. On the other hand, it maintains pathological joint load and lower limb kinematics with potentially detrimental outcomes. The hybrid technique can be performed in most cases. It circumvents complications associated with osteotomies and brings lower limb axes closer to native alignment. On the other hand, it creates some intra-articular imbalances, which may require soft tissue releases and/or constrained implants. Correcting the extra-articular deformity (through an osteotomy) in conjunction with joint resurfacing TKA represents the only true kinematic alignment technique, as it aims to reproduce native knee laxity and overall lower limb axis.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297404/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virtual reality-based therapy for chronic low back and neck pain: a systematic review with meta-analysis. 基于虚拟现实技术的慢性腰背痛和颈椎痛治疗:系统综述与荟萃分析。
IF 4.3 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-07-01 DOI: 10.1530/EOR-23-0197
Juan Manuel Henríquez-Jurado, María Catalina Osuna-Pérez, Héctor García-López, Rafael Lomas-Vega, María Del Carmen López-Ruiz, Esteban Obrero-Gaitán, Irene Cortés-Pérez

Purpose: To compile all the scientific evidence available to date to evaluate the effect of virtual reality based therapy (VRBT) on reducing pain intensity, kinesiophobia, and associated disability, and on increasing the hr-QoL in patients with chronic neck pain (CNP) or chronic low back pain (CLBP).

Methods: Studies published in PubMed Medline, SCOPUS, Web of Science, CINAHL Complete, and Physiotherapy Evidence Database (PEDro) up to June 2023 were searched. All searches followed the PICOS Framework. Two authors independently screened the studies found in the searches. Any differences of opinion regarding the selection of studies were settled by a third author.

Results: Twenty-five RCTs, published between 2013 and 2022, providing data from 1261 patients (20 RCTs) with CLBP and 261 patients (five RCTs) with CNP, were included. In reducing pain intensity for patients with CLBP, meta-analyses showed that VRBT is effective in reducing pain just to the end of the intervention, and this effect could be maintained 1 and 6 months after the therapy.

Conclusion: VRBT was found to be better than therapeutic exercise (TE), sham, and no intervention (NI), showing a major effect when VRBT was used as a complementary therapy to conventional physiotherapy (CPT). Further, VRBT showed an immediate effect and immersive VRBT was the most adequate VRBT modality in reducing pain in CNP patients. No differences were found between non-immersive VRBT and immersive VRBT in reducing pain, kinesiophobia, disability, and hr-QoL in patients with CLBP.

目的:汇编迄今为止所有可用的科学证据,以评估虚拟现实疗法(VRBT)对减轻慢性颈痛(CNP)或慢性腰痛(CLBP)患者的疼痛强度、运动恐惧和相关残疾以及提高其生活质量的影响:方法:检索截至 2023 年 6 月在 PubMed Medline、SCOPUS、Web of Science、CINAHL Complete 和物理治疗证据数据库 (PEDro) 上发表的研究。所有检索均遵循 PICOS 框架。两位作者对检索中发现的研究进行了独立筛选。关于研究选择的任何意见分歧均由第三位作者解决:共纳入了 25 项研究,这些研究发表于 2013 年至 2022 年之间,提供了 1261 名 CLBP 患者(20 项研究)和 261 名 CNP 患者(5 项研究)的数据。荟萃分析表明,在降低CLBP患者的疼痛强度方面,VRBT能在干预结束时有效减轻疼痛,而且这种效果能在治疗1个月和6个月后保持:结论:研究发现,VRBT 的效果优于治疗性运动(TE)、假干预和无干预(NI),显示出 VRBT 作为传统物理治疗(CPT)的辅助疗法具有显著效果。此外,VRBT 显示出了立竿见影的效果,而沉浸式 VRBT 是最能减轻 CNP 患者疼痛的 VRBT 模式。非沉浸式 VRBT 和沉浸式 VRBT 在减轻慢性阻塞性肺病患者的疼痛、运动恐惧、残疾和生活质量方面没有差异。
{"title":"Virtual reality-based therapy for chronic low back and neck pain: a systematic review with meta-analysis.","authors":"Juan Manuel Henríquez-Jurado, María Catalina Osuna-Pérez, Héctor García-López, Rafael Lomas-Vega, María Del Carmen López-Ruiz, Esteban Obrero-Gaitán, Irene Cortés-Pérez","doi":"10.1530/EOR-23-0197","DOIUrl":"10.1530/EOR-23-0197","url":null,"abstract":"<p><strong>Purpose: </strong>To compile all the scientific evidence available to date to evaluate the effect of virtual reality based therapy (VRBT) on reducing pain intensity, kinesiophobia, and associated disability, and on increasing the hr-QoL in patients with chronic neck pain (CNP) or chronic low back pain (CLBP).</p><p><strong>Methods: </strong>Studies published in PubMed Medline, SCOPUS, Web of Science, CINAHL Complete, and Physiotherapy Evidence Database (PEDro) up to June 2023 were searched. All searches followed the PICOS Framework. Two authors independently screened the studies found in the searches. Any differences of opinion regarding the selection of studies were settled by a third author.</p><p><strong>Results: </strong>Twenty-five RCTs, published between 2013 and 2022, providing data from 1261 patients (20 RCTs) with CLBP and 261 patients (five RCTs) with CNP, were included. In reducing pain intensity for patients with CLBP, meta-analyses showed that VRBT is effective in reducing pain just to the end of the intervention, and this effect could be maintained 1 and 6 months after the therapy.</p><p><strong>Conclusion: </strong>VRBT was found to be better than therapeutic exercise (TE), sham, and no intervention (NI), showing a major effect when VRBT was used as a complementary therapy to conventional physiotherapy (CPT). Further, VRBT showed an immediate effect and immersive VRBT was the most adequate VRBT modality in reducing pain in CNP patients. No differences were found between non-immersive VRBT and immersive VRBT in reducing pain, kinesiophobia, disability, and hr-QoL in patients with CLBP.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative management following osteotomies around the knee: a narrative review. 膝关节周围截骨术后管理:综述。
IF 4.3 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-07-01 DOI: 10.1530/EOR-23-0153
Felix Christoph Finger, Steffen Schröter, Christoph Ihle, Moritz Herbst, Tina Histing, Marc-Daniel Ahrend

The present narrative review provides a summary of postoperative therapy modalities and their effectiveness following osteotomies around the knee. The topics that are discussed in the scientific discourse include support of cartilage cell regeneration, pain management, drainage insertion, tourniquet use, pharmacological and mechanical thromboembolism prophylaxis, weight-bearing protocols and bone consolidation. There is evidence for the use of pharmacological thromboembolism prophylaxis and weight-bearing protocols. A standardized postoperative treatment concept following osteotomies around the knee cannot be derived due to lack of evidence for the other topics in current literature.

本综述概述了膝关节周围截骨术后的治疗方法及其效果。科学论述中讨论的主题包括支持软骨细胞再生、疼痛管理、引流插入、止血带使用、药物和机械血栓栓塞预防、负重方案和骨巩固。有证据表明可以使用药物预防血栓栓塞和负重方案。由于目前文献中缺乏关于其他主题的证据,因此无法得出膝关节周围截骨术后的标准化治疗概念。
{"title":"Postoperative management following osteotomies around the knee: a narrative review.","authors":"Felix Christoph Finger, Steffen Schröter, Christoph Ihle, Moritz Herbst, Tina Histing, Marc-Daniel Ahrend","doi":"10.1530/EOR-23-0153","DOIUrl":"10.1530/EOR-23-0153","url":null,"abstract":"<p><p>The present narrative review provides a summary of postoperative therapy modalities and their effectiveness following osteotomies around the knee. The topics that are discussed in the scientific discourse include support of cartilage cell regeneration, pain management, drainage insertion, tourniquet use, pharmacological and mechanical thromboembolism prophylaxis, weight-bearing protocols and bone consolidation. There is evidence for the use of pharmacological thromboembolism prophylaxis and weight-bearing protocols. A standardized postoperative treatment concept following osteotomies around the knee cannot be derived due to lack of evidence for the other topics in current literature.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traumatic pelvic ring fracture during pregnancy: a systematic review. 孕期创伤性骨盆环骨折:系统性综述。
IF 4.3 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-07-01 DOI: 10.1530/EOR-23-0164
Arvin Eslami, Mohammadreza Chehrassan, Shaya Alimoghadam, Karim Pisoudeh, Amir Kasaeian, Omid Elahifar

Purpose: This systematic review aims to investigate the management and outcomes of pelvic ring fractures (PRFs) during pregnancy, emphasizing maternal and fetal mortality rates, mechanisms of injury, and treatment modalities.

Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a comprehensive search of databases from 2000 to 2023, identifying 33 relevant studies. Data extraction included demographics, fracture types, treatment methods, and outcomes. Risk of bias was assessed using the JBI criteria.

Results: Maternal mortality stood at 9.1%, with fetal mortality at 42.4%. Maternal factors impacting mortality included head trauma and hemodynamic instability. Fetal mortality correlated with mechanisms like motor vehicle accidents and maternal vital signs. Surgical and conservative treatments were applied, with a majority of pelvic surgeries performed before delivery. External fixators proved effective in fracture stabilization.

Conclusion: Pelvic ring fractures during pregnancy present significant risks to maternal and fetal health. Early stabilization and vigilant monitoring of maternal vital signs are crucial. Vaginal bleeding/discharge serves as a critical fetal risk indicator. The choice between surgical and conservative treatment minimally influenced outcomes. Multidisciplinary collaboration and tailored interventions are essential in managing these complex cases.

目的:本系统综述旨在研究妊娠期骨盆环骨折(PRFs)的处理和结果,重点关注孕产妇和胎儿死亡率、损伤机制和治疗方式:根据《系统综述和元分析首选报告项目》指南,我们对 2000 年至 2023 年的数据库进行了全面检索,确定了 33 项相关研究。数据提取包括人口统计学、骨折类型、治疗方法和结果。采用JBI标准对偏倚风险进行了评估:产妇死亡率为 9.1%,胎儿死亡率为 42.4%。影响死亡率的产妇因素包括头部创伤和血流动力学不稳定。胎儿死亡率与机动车事故和产妇生命体征等因素有关。手术和保守治疗均有应用,大部分骨盆手术在分娩前进行。事实证明,外固定器能有效稳定骨折:结论:妊娠期骨盆环骨折对母体和胎儿的健康构成重大风险。尽早稳定病情并警惕监测产妇生命体征至关重要。阴道出血/出院是一个重要的胎儿风险指标。选择手术治疗还是保守治疗对结果的影响微乎其微。在处理这些复杂病例时,多学科协作和有针对性的干预措施至关重要。
{"title":"Traumatic pelvic ring fracture during pregnancy: a systematic review.","authors":"Arvin Eslami, Mohammadreza Chehrassan, Shaya Alimoghadam, Karim Pisoudeh, Amir Kasaeian, Omid Elahifar","doi":"10.1530/EOR-23-0164","DOIUrl":"10.1530/EOR-23-0164","url":null,"abstract":"<p><strong>Purpose: </strong>This systematic review aims to investigate the management and outcomes of pelvic ring fractures (PRFs) during pregnancy, emphasizing maternal and fetal mortality rates, mechanisms of injury, and treatment modalities.</p><p><strong>Methods: </strong>Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a comprehensive search of databases from 2000 to 2023, identifying 33 relevant studies. Data extraction included demographics, fracture types, treatment methods, and outcomes. Risk of bias was assessed using the JBI criteria.</p><p><strong>Results: </strong>Maternal mortality stood at 9.1%, with fetal mortality at 42.4%. Maternal factors impacting mortality included head trauma and hemodynamic instability. Fetal mortality correlated with mechanisms like motor vehicle accidents and maternal vital signs. Surgical and conservative treatments were applied, with a majority of pelvic surgeries performed before delivery. External fixators proved effective in fracture stabilization.</p><p><strong>Conclusion: </strong>Pelvic ring fractures during pregnancy present significant risks to maternal and fetal health. Early stabilization and vigilant monitoring of maternal vital signs are crucial. Vaginal bleeding/discharge serves as a critical fetal risk indicator. The choice between surgical and conservative treatment minimally influenced outcomes. Multidisciplinary collaboration and tailored interventions are essential in managing these complex cases.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Achilles tendon complications of fluoroquinolone treatment: a molecule-stratified systematic review and meta-analysis. 氟喹诺酮治疗的跟腱并发症:分子分层系统综述和荟萃分析。
IF 4.3 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-07-01 DOI: 10.1530/EOR-23-0181
Alessandro Sangiorgio, Martina Sirone, Federico Maria Adravanti, Enrique Adrian Testa, Martin Riegger, Giuseppe Filardo

Purpose: The association between fluoroquinolone intake and Achilles tendinopathy (AT) or Achilles tendon rupture (ATR) is widely documented. However, it is not clear whether different molecules have the same effect on these complications. The purpose of this study was to document Achilles tendon complications for the most prescribed fluoroquinolones molecules.

Methods: A literature search was performed on Pubmed, Cochrane, Embase, and Web of Science databases up to April 2023. Inclusion criteria: studies of any level of evidence, written in English, documenting the prevalence of AT/ATR after fluoroquinolone consumption and stratifying the results for each type of molecule. The Downs and Black's 'Checklist for Measuring Quality' was used to evaluate the risk of bias.

Results: Twelve studies investigating 439,299 patients were included (59.7% women, 40.3% men, mean age: 53.0 ± 15.6 years). The expected risk of AT/ATR was 0.17% (95% CI: 0.15-0.19, standard error (s.e.): 0.24) for levofloxacin, 0.17% (95% CI: 0.16-0.19, s.e.: 0.20) for ciprofloxacin, 1.40% (95% CI: 0.88-2.03, s.e.: 2.51) for ofloxacin, and 0.31% (95% CI: 0.23-0.40, s.e.: 0.77) for the other molecules. The comparison between groups documented a significantly higher AT/ATR rate in the ofloxacin group (P < 0.0001 for each comparison). Levofloxacin and ciprofloxacin showed the same risk (P = n.s.). The included studies showed an overall good quality.

Conclusion: Ofloxacin demonstrated a significantly higher rate of AT/ATR complications in the adult population, while levofloxacin and ciprofloxacin showed a safer profile compared to all the other molecules. More data are needed to identify other patient and treatment-related factors influencing the risk of musculoskeletal complications.

目的:氟喹诺酮类药物的摄入与跟腱病(AT)或跟腱断裂(ATR)之间的关联已被广泛记录。然而,尚不清楚不同的分子对这些并发症是否有相同的影响。本研究旨在记录处方量最大的氟喹诺酮类药物的跟腱并发症:方法:在 Pubmed、Cochrane、Embase 和 Web of Science 数据库中进行文献检索,时间截至 2023 年 4 月。纳入标准:任何证据级别的研究,以英文撰写,记录服用氟喹诺酮类药物后AT/ATR的发生率,并对每种分子类型的结果进行分层。采用唐斯和布莱克的 "质量衡量清单 "来评估偏倚风险:共纳入了 12 项研究,调查了 439,299 名患者(59.7% 为女性,40.3% 为男性,平均年龄:53.0 ± 15.6 岁)。AT/ATR 的预期风险为 0.17%(95% CI:0.15-0.19,标准误差 (s.e.):0.24):左氧氟沙星为 0.17%(95% CI:0.16-0.19,标准误差(s.e.):0.24),环丙沙星为 0.17%(95% CI:0.16-0.19,标准误差(s.e.):0.20),氧氟沙星为 1.40%(95% CI:0.88-2.03,标准误差(s.e.):2.51),其他分子为 0.31%(95% CI:0.23-0.40,标准误差(s.e.):0.77)。组间比较显示,氧氟沙星组的 AT/ATR 率明显更高(各组间比较的 P < 0.0001)。左氧氟沙星和环丙沙星的风险相同(P = n.s.)。纳入的研究总体质量良好:结论:氧氟沙星在成人人群中显示出明显较高的AT/ATR并发症发生率,而左氧氟沙星和环丙沙星与所有其他分子相比显示出更安全的特征。还需要更多数据来确定影响肌肉骨骼并发症风险的其他患者和治疗相关因素。
{"title":"Achilles tendon complications of fluoroquinolone treatment: a molecule-stratified systematic review and meta-analysis.","authors":"Alessandro Sangiorgio, Martina Sirone, Federico Maria Adravanti, Enrique Adrian Testa, Martin Riegger, Giuseppe Filardo","doi":"10.1530/EOR-23-0181","DOIUrl":"10.1530/EOR-23-0181","url":null,"abstract":"<p><strong>Purpose: </strong>The association between fluoroquinolone intake and Achilles tendinopathy (AT) or Achilles tendon rupture (ATR) is widely documented. However, it is not clear whether different molecules have the same effect on these complications. The purpose of this study was to document Achilles tendon complications for the most prescribed fluoroquinolones molecules.</p><p><strong>Methods: </strong>A literature search was performed on Pubmed, Cochrane, Embase, and Web of Science databases up to April 2023. Inclusion criteria: studies of any level of evidence, written in English, documenting the prevalence of AT/ATR after fluoroquinolone consumption and stratifying the results for each type of molecule. The Downs and Black's 'Checklist for Measuring Quality' was used to evaluate the risk of bias.</p><p><strong>Results: </strong>Twelve studies investigating 439,299 patients were included (59.7% women, 40.3% men, mean age: 53.0 ± 15.6 years). The expected risk of AT/ATR was 0.17% (95% CI: 0.15-0.19, standard error (s.e.): 0.24) for levofloxacin, 0.17% (95% CI: 0.16-0.19, s.e.: 0.20) for ciprofloxacin, 1.40% (95% CI: 0.88-2.03, s.e.: 2.51) for ofloxacin, and 0.31% (95% CI: 0.23-0.40, s.e.: 0.77) for the other molecules. The comparison between groups documented a significantly higher AT/ATR rate in the ofloxacin group (P < 0.0001 for each comparison). Levofloxacin and ciprofloxacin showed the same risk (P = n.s.). The included studies showed an overall good quality.</p><p><strong>Conclusion: </strong>Ofloxacin demonstrated a significantly higher rate of AT/ATR complications in the adult population, while levofloxacin and ciprofloxacin showed a safer profile compared to all the other molecules. More data are needed to identify other patient and treatment-related factors influencing the risk of musculoskeletal complications.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adolescent idiopathic scoliosis in adulthood. 成年后的青少年特发性脊柱侧凸。
IF 4.3 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-07-01 DOI: 10.1530/EOR-23-0162
Kashif Ansari, Manjot Singh, Jake R McDermott, Jerzy A Gregorczyk, Mariah Balmaceno-Criss, Mohammad Daher, Christopher L McDonald, Bassel G Diebo, Alan H Daniels

Adolescent idiopathic scoliosis (AIS) is an abnormal coronal curvature of the spine that most commonly presents in adolescence. While it may be asymptomatic, AIS can cause pain, cosmetic deformity, and physical and psychological disability with curve progression. As adolescents with AIS enter adulthood, condition outcomes vary with some experiencing curve stabilization and others noting further curve progression, chronic pain, osteoporosis/fractures, declines in pulmonary and functional capacity, among others. Regular monitoring and individualized management by healthcare professionals are crucial to address the diverse challenges and provide appropriate support for a fulfilling adult life with AIS. This review examines the prevalence, risk factors, presenting symptoms, diagnosis, management, and complications of AIS in the adult population, informing targeted interventions by clinicians caring for adult patients with AIS.

青少年特发性脊柱侧弯症(AIS)是一种异常的脊柱冠状弯曲,最常见于青少年时期。虽然可能没有任何症状,但随着脊柱弯曲的发展,AIS 可导致疼痛、外观畸形以及生理和心理残疾。当患有 AIS 的青少年步入成年期时,病情的结果各不相同,有些人的曲线趋于稳定,有些人的曲线则进一步恶化,出现慢性疼痛、骨质疏松/骨折、肺功能和机能下降等症状。医护人员的定期监测和个性化管理对于应对不同的挑战和提供适当的支持,使患有 AIS 的成年患者过上充实的生活至关重要。本综述探讨了 AIS 在成年人群中的患病率、风险因素、主要症状、诊断、管理和并发症,为护理 AIS 成年患者的临床医生提供有针对性的干预措施。
{"title":"Adolescent idiopathic scoliosis in adulthood.","authors":"Kashif Ansari, Manjot Singh, Jake R McDermott, Jerzy A Gregorczyk, Mariah Balmaceno-Criss, Mohammad Daher, Christopher L McDonald, Bassel G Diebo, Alan H Daniels","doi":"10.1530/EOR-23-0162","DOIUrl":"10.1530/EOR-23-0162","url":null,"abstract":"<p><p>Adolescent idiopathic scoliosis (AIS) is an abnormal coronal curvature of the spine that most commonly presents in adolescence. While it may be asymptomatic, AIS can cause pain, cosmetic deformity, and physical and psychological disability with curve progression. As adolescents with AIS enter adulthood, condition outcomes vary with some experiencing curve stabilization and others noting further curve progression, chronic pain, osteoporosis/fractures, declines in pulmonary and functional capacity, among others. Regular monitoring and individualized management by healthcare professionals are crucial to address the diverse challenges and provide appropriate support for a fulfilling adult life with AIS. This review examines the prevalence, risk factors, presenting symptoms, diagnosis, management, and complications of AIS in the adult population, informing targeted interventions by clinicians caring for adult patients with AIS.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of the combination of various pharmacological treatments and exercise on knee osteoarthritis: a systematic review and network meta-analysis. 各种药物治疗与运动相结合对膝关节骨性关节炎的影响:系统综述和网络荟萃分析。
IF 4.3 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-07-01 DOI: 10.1530/EOR-23-0136
Hsiao-Yi Cheng, Chun-Wei Liang, Yu-Hao Lee, Timporn Vitoonpong, Chun-De Liao, Shih-Wei Huang

Purpose: The combination of pharmacological and non-pharmacological interventions is strongly recommended by current guidelines for knee osteoarthritis. However, few systematic reviews have validated their combined efficacy. In this study, we investigated the effects of the combination of pharmacological agents and exercise on knee osteoarthritis.

Methods: Randomized controlled trials that investigated the efficacy of pharmacological agents combined with exercise for knee osteoarthritis were searched in PubMed, Embase, and Cochrane Library up to February 2024. The network meta-analysis was performed within the frequentist framework. Standardized mean difference (SMD) with 95% CI was estimated for pain and function. Grading of recommendations, assessment, development, and evaluations were used to evaluate the certainty of evidence.

Results: In total, 71 studies were included. The combination therapy outperformed pharmacological or exercise therapy alone. Among the various pharmacological agents combined with exercise, mesenchymal stem cell injection was ranked the best for short-term pain reduction (SMD: -1.53, 95% CI: -1.92 to -1.13, high certainty), followed by botulinum toxin A, dextrose, and platelet-rich plasma. For long-term pain relief, dextrose prolotherapy was the optimal (SMD: -1.76, 95% CI: -2.65 to -0.88, moderate certainty), followed by mesenchymal stem cells, platelet rich in growth factor, and platelet-rich plasma.

Conclusion: Exercise programs should be incorporated into clinical practice and trial design. For patients undergoing exercise therapies, mesenchymal stem cell, dextrose, platelet-rich plasma, platelet rich in growth factor, and botulinum toxin A may be the optimal agents.

目的:目前的膝关节骨性关节炎治疗指南强烈建议将药物治疗和非药物治疗相结合。然而,很少有系统性综述对其综合疗效进行验证。在这项研究中,我们调查了药物和运动相结合对膝关节骨性关节炎的影响:截至 2024 年 2 月,我们在 PubMed、Embase 和 Cochrane 图书馆中检索了研究药理药剂与运动相结合对膝骨关节炎疗效的随机对照试验。网络荟萃分析在频数主义框架内进行。对疼痛和功能的标准化平均差(SMD)及 95% CI 进行了估算。采用建议、评估、发展和评价分级来评估证据的确定性:结果:共纳入 71 项研究。综合疗法的疗效优于单纯的药物疗法或运动疗法。在与运动相结合的各种药物疗法中,间充质干细胞注射的短期止痛效果最佳(SMD:-1.53,95% CI:-1.92 至-1.13,高度确定性),其次是肉毒杆菌毒素 A、葡萄糖和富血小板血浆。就长期疼痛缓解而言,葡萄糖增殖疗法是最佳疗法(SMD:-1.76,95% CI:-2.65至-0.88,中等确定性),其次是间充质干细胞、富含生长因子的血小板和富血小板血浆:结论:运动计划应纳入临床实践和试验设计中。对于接受运动疗法的患者,间充质干细胞、葡萄糖、富血小板血浆、富血小板生长因子和肉毒杆菌毒素A可能是最佳药物。
{"title":"Effects of the combination of various pharmacological treatments and exercise on knee osteoarthritis: a systematic review and network meta-analysis.","authors":"Hsiao-Yi Cheng, Chun-Wei Liang, Yu-Hao Lee, Timporn Vitoonpong, Chun-De Liao, Shih-Wei Huang","doi":"10.1530/EOR-23-0136","DOIUrl":"10.1530/EOR-23-0136","url":null,"abstract":"<p><strong>Purpose: </strong>The combination of pharmacological and non-pharmacological interventions is strongly recommended by current guidelines for knee osteoarthritis. However, few systematic reviews have validated their combined efficacy. In this study, we investigated the effects of the combination of pharmacological agents and exercise on knee osteoarthritis.</p><p><strong>Methods: </strong>Randomized controlled trials that investigated the efficacy of pharmacological agents combined with exercise for knee osteoarthritis were searched in PubMed, Embase, and Cochrane Library up to February 2024. The network meta-analysis was performed within the frequentist framework. Standardized mean difference (SMD) with 95% CI was estimated for pain and function. Grading of recommendations, assessment, development, and evaluations were used to evaluate the certainty of evidence.</p><p><strong>Results: </strong>In total, 71 studies were included. The combination therapy outperformed pharmacological or exercise therapy alone. Among the various pharmacological agents combined with exercise, mesenchymal stem cell injection was ranked the best for short-term pain reduction (SMD: -1.53, 95% CI: -1.92 to -1.13, high certainty), followed by botulinum toxin A, dextrose, and platelet-rich plasma. For long-term pain relief, dextrose prolotherapy was the optimal (SMD: -1.76, 95% CI: -2.65 to -0.88, moderate certainty), followed by mesenchymal stem cells, platelet rich in growth factor, and platelet-rich plasma.</p><p><strong>Conclusion: </strong>Exercise programs should be incorporated into clinical practice and trial design. For patients undergoing exercise therapies, mesenchymal stem cell, dextrose, platelet-rich plasma, platelet rich in growth factor, and botulinum toxin A may be the optimal agents.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297400/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical management of renal cell carcinoma: integrating current approaches with advances in bone metastasis treatment. 肾细胞癌的实用管理:将当前方法与骨转移治疗的进展相结合。
IF 4.3 2区 医学 Q1 Medicine Pub Date : 2024-06-03 DOI: 10.1530/EOR-23-0178
Irina-Anca Eremia, Bogdan Serban, Mihnea Popa, Adela Iancu, Silvia Nica, Catalin Cirstoiu

Renal cell carcinoma (RCC) is a common type of tumor that can develop in the kidney. It is responsible for around one-third of all cases of neoplasms. RCC manifests itself in a variety of distinct subtypes. The most frequent of which is clear cell RCC, followed by papillary and chromophobe RCC. RCC has the potential for metastasis to a variety of organs; nevertheless, bone metastases are one of the most common and potentially fatal complications. These bone metastases are characterized by osteolytic lesions that can result in pathological fractures, hypercalcemia, and other complications, which can ultimately lead to a deterioration in quality of life and an increase morbidity. While nephrectomy remains a foundational treatment for RCC, emerging evidence suggests that targeted therapies, including tyrosine kinase inhibitors and T cell checkpoint inhibitors, may offer effective alternatives, potentially obviating the need for adjuvant nephrectomy in certain cases of metastatic RCC Bone metastases continue to be a difficult complication of RCC, which is why more research is required to enhance patient outcome.

肾细胞癌(RCC)是肾脏中常见的一种肿瘤。在所有肿瘤病例中,约有三分之一是由它引起的。RCC 有多种不同的亚型。其中最常见的是透明细胞型 RCC,其次是乳头状和嗜铬细胞型 RCC。RCC 有可能转移到多种器官,但骨转移是最常见的并发症之一,也是潜在的致命并发症。这些骨转移以溶骨性病变为特征,可导致病理性骨折、高钙血症和其他并发症,最终导致生活质量下降和发病率增加。虽然肾切除术仍是治疗 RCC 的基础疗法,但新的证据表明,包括酪氨酸激酶抑制剂和 T 细胞检查点抑制剂在内的靶向疗法可能会提供有效的替代疗法,在某些转移性 RCC 病例中可能无需进行辅助性肾切除术 骨转移仍是 RCC 的难治并发症,因此需要开展更多研究来改善患者的预后。
{"title":"Practical management of renal cell carcinoma: integrating current approaches with advances in bone metastasis treatment.","authors":"Irina-Anca Eremia, Bogdan Serban, Mihnea Popa, Adela Iancu, Silvia Nica, Catalin Cirstoiu","doi":"10.1530/EOR-23-0178","DOIUrl":"10.1530/EOR-23-0178","url":null,"abstract":"<p><p>Renal cell carcinoma (RCC) is a common type of tumor that can develop in the kidney. It is responsible for around one-third of all cases of neoplasms. RCC manifests itself in a variety of distinct subtypes. The most frequent of which is clear cell RCC, followed by papillary and chromophobe RCC. RCC has the potential for metastasis to a variety of organs; nevertheless, bone metastases are one of the most common and potentially fatal complications. These bone metastases are characterized by osteolytic lesions that can result in pathological fractures, hypercalcemia, and other complications, which can ultimately lead to a deterioration in quality of life and an increase morbidity. While nephrectomy remains a foundational treatment for RCC, emerging evidence suggests that targeted therapies, including tyrosine kinase inhibitors and T cell checkpoint inhibitors, may offer effective alternatives, potentially obviating the need for adjuvant nephrectomy in certain cases of metastatic RCC Bone metastases continue to be a difficult complication of RCC, which is why more research is required to enhance patient outcome.</p>","PeriodicalId":48598,"journal":{"name":"Efort Open Reviews","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11195343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Efort Open Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1